A new orange-red thermally activated delayed fluorescence (TADF) emitter is designed and synthesized by incorporating a fluorine-substituted quinoxaline as an electron-acceptor and a phenoxazine as an electron-donor. The rational molecular design enables small singlet-triplet energy splitting (ΔEST) and high fluorescence radiative rate (k) for long-wavelength TADF emitters. The organic light emitting diodes (OLEDs) employing the new TADF emitter achieve maximum external quantum efficiencies (EQEs) of 13.9% and 9.0% for the vacuum- and solution-processed OLEDs, respectively.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: